ASCO GI 2023 Conference Coverage

 

ASCO GI 2023 Conference Coverage
B

ASCO GI 2023 Overall Survival in Gastrointestinal Neuroendocrine Tumors Based on Primary Site, Stage, and Surgery

By ASCO GI 2023 Conference Coverage FEATURING Bahar Laderian
By ASCO GI 2023 Conference Coverage FEATURING Bahar Laderian
154 views
February 23, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

10:25
Exelixis

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam
Videos
07:46
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Phase II Clinical Trial to Study the Use of Cabozantini…

Feat. S. L. Chan
12:04
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Preliminary Efficacy and Correlative Results of the Pha…

Feat. K. Spencer
06:17
ASCO GI 2023 Conference Coverage

ASCO GI 2023 INTEGRATE IIa Randomised, Double-Blind, Phase III Study…

Feat. N. Pavlakis
06:25
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Overall Survival in Gastrointestinal Neuroendocrine Tum…

Feat. B. Laderian
05:13
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Primary Endpoint Results of a Randomized, Double-Blind,…

Feat. J. Furuse
13:21
ASCO GI 2023 Conference Coverage

ASCO GI 2023 TIMES Trial: Advancing Precision Immunotherapy for Gast…

Feat. D. Zeng
09:24
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Randomized Phase II VELO Clinical Trial: Panitumumab + …

Feat. S. Napolitano
11:02
ASCO GI 2023 Conference Coverage

ASCO GI 2023 3-Year Follow-Up From CheckMate 649: Nivo + Chemo vs. C…

Feat. Y. Y. Janjigian
30:57
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Final Surgical Salvage Results From OPERA Phase 3 Rando…

Feat. A. Sun Myint
08:54
ASCO GI 2023 Conference Coverage

ASCO GI 2023 CRC Highlights: Phase 3 SUNLIGHT & PARADIGM Trials

Feat. A. Venook
09:02
ASCO GI 2023 Conference Coverage

ASCO GI 2023: A Study of Pembro in Combination With Y90 Radioemboliz…

Feat. A. Somasundaram
05:56
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Phase II IMMULAB Trial: IO With Pembro in Combination W…

Feat. A. Vogel
05:26
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Results From the TAPUR Study: Pertuzumab + Trastuzumab …

Feat. T. Cannon
10:19
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Promoting Multidisciplinary Care for Patients With Unre…

Feat. A. Baron
07:46
ASCO GI 2023 Conference Coverage

FGFR2-Amplified Gastroesophageal Adenocarcinoma Is a Distinct Genomi…

Feat. B. Shariff
06:59
ASCO GI 2023 Conference Coverage

ASCO GI 2023 CCTG HE.1 - Phase 3 Study: Palliative RT for Symptomati…

Feat. L. Dawson
09:43
ASCO GI 2023 Conference Coverage

ASCO GI 2023 NRG/RTOG 1112 Randomized Phase 3 Study: Sorafenib vs. S…

Feat. L. Dawson
05:32
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Continuous Maintenance Capecitabine Dosing for Advanced…

Feat. R. Mukherji
20:09
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Debate: For a Fit Patient With Unresectable Metastatic …

Feat. K. Shiu
04:06
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Phase Ib OBERTO-201 Study: Evaluating Safety, Tolerabil…

Feat. J. Hubbard
06:08
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Survival Outcomes and Functional Results of VOLTAGE-A: …

Feat. Y. Tsukada
23:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta
10:41
ASCO GI 2023 Conference Coverage

ASCO GI 2023 NAPOLI-3 Randomized, Open-Label Phase 3 Study: Liposoma…

Feat. Z. Wainberg
07:49
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Preliminary Clinical Results of the NERDY Study: Immuno…

Feat. A. Anna Prete
05:32
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Phase 3 Randomized SWOG 1815 Trial: Gemcitabine, Cispla…

Feat. R. Shroff
05:29
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Phase 3 BREAKWATER Study Safety Lead-In: Encorafenib + …

Feat. S. Kopetz
16:19
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Exploring Immunotherapy Combinations for DDR-Deficient …

Feat. K. Reiss Binder
08:15
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Zanidatamab + Chemo as 1L Treatment for HER2-Expressing…

Feat. E. Elimova
04:20
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Final Results of the Phase II RE-ExPEL Study: Ramucirum…

Feat. T. Oliver Götze
12:31
ASCO GI 2023 Conference Coverage

ASCO GI 2023 29-Month Follow-Up From CheckMate 648: Nivo + Chemo or …

Feat. K. Kato
07:20
ASCO GI 2023 Conference Coverage

ASCO GI 2023 ctDNA Informs Clinical Practice in Patients With Recurr…

Feat. R. Mehta
06:52
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Multicenter, Single-Arm, Multi-Cohort, Phase II INFINIT…

Feat. F. Pietrantonio
11:46
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Debate: For a Fit Patient With Unresectable Metastatic …

Feat. A. Shergill
09:47
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Neoadjuvant Immunotherapy in Localized dMMR CRC

Feat. S. Chakrabarti
09:12
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Comparative Analysis of the Molecular Profile and Tumor…

Feat. A. Alqahtani
04:46
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Confidence Study: Effectiveness & Safety of Encoraf…

Feat. A. Fernandez Montes
07:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 ctDNA Dynamics and Clinical Outcome in mCRC Patients Un…

Feat. M. Ghidini
09:41
ASCO GI 2023 Conference Coverage

ASCO GI 2023 New Prognostic Index of Advanced Gastric Cancer Using t…

Feat. D. Takahari
04:41
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Characterization of Long-Term Survivors in the TOPAZ-1 …

Feat. M. Bouattour
12:06
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Surgical Viewpoint on Non-Operative Management of Recta…

Feat. T. Konishi
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
05:34
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Biomarker Study of The Phase III PARADIGM Trial: Negati…

Feat. K. Shitara
07:51
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Phase 3 SPOTLIGHT Study Primary Results: Zolbetuximab +…

Feat. K. Shitara
07:40
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Kinetics of Postoperative Circulating cfDNA and Impact …

Feat. S. Cohen
06:32
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Analysis of HLA Gene Expression in Patients With dMMR/M…

Feat. H. Lenz
07:43
ASCO GI 2023 Conference Coverage

ASCO GI 2023 ctDNA for Response Assessment in Patients With Anal Can…

Feat. J. Alvarez
06:55
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Evaluation of Clinical Benefit and PFS Ratio of Targete…

Feat. M. Niger
05:19
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Phase 3 STELLAR-303 Study: XL092 in Combination With At…

Feat. J. Hecht
10:26
ASCO GI 2023 Conference Coverage

Phase 3 Randomized SUNLIGHT Study: Trifluridine/Tipiracil + Bevacizu…

Feat. J. Tabernero
06:16
ASCO GI 2023 Conference Coverage

ASCO GI 2023 on Organ Preservation and Total Neoadjuvant Therapy for…

Feat. P. Romesser
06:55
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Results From a Phase 1a/1b Study: Botensilimab, a Novel…

Feat. A. El-Khoueiry
10:41
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Phase 2, Randomized, Double-Blind, Placebo-Controlled I…

Feat. A. El-Khoueiry
08:47
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Use of ctDNA for Early Assessment of Treatment Response…

Feat. P. Kasi
13:36
ASCO GI 2023 Conference Coverage

ASCO GI 2023 CTCs as Liquid Biopsies in Patients With mCRC vs. Other…

Feat. P. Kasi
06:32
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Randomized Phase III FIRE-4 study (AIO KRK-0114): Inves…

Feat. S. Stintzing
06:28
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Survival Analysis of the Phase II Randomized DEEPER Tri…

Feat. Y. Sunakawa